08/20/2024
7:16 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
7:42 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
08/20/2024
5:24 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:27 PM | BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
5:31 PM | BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:27 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:29 PM | BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/08/2024
3:39 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
4:06 PM | BridgeBio Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/01/2024
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
7:16 PM | BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/23/2024
3:12 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
4:38 PM | BridgeBio Pharma (Issuer)
HOMCY CHARLES J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:38 PM | BridgeBio Pharma (Issuer)
Lo Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
Hassan Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:39 PM | BridgeBio Pharma (Issuer)
MOMTAZEE JAMES C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:40 PM | BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:42 PM | BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:42 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:34 PM | AGUIAR ERIC (Reporting)
BridgeBio Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:35 PM | BridgeBio Pharma (Issuer)
Cook Jennifer E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:36 PM | BridgeBio Pharma (Issuer)
Dachille Douglas A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
4:36 PM | BridgeBio Pharma (Issuer)
DANIELS RONALD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:01 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
3:53 PM | BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:13 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:15 PM | BridgeBio Pharma (Filer)
| Form 424B5 | |
03/04/2024
6:00 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
6:15 PM | BridgeBio Pharma (Subject)
Kumar Neil (Filed by)
| Form SC 13G/A | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
BridgeBio Pharma (Subject)
| Form SC 13G/A | |
01/23/2024
9:16 AM | BridgeBio Pharma (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024
3:10 PM | BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
6:30 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
4:14 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
4:33 PM | BridgeBio Pharma (Subject)
MCCORMICK FRANK (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
3:15 PM | BridgeBio Pharma (Subject)
Scott Randal W. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
3:20 PM | BridgeBio Pharma (Subject)
Scott Randal W. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳 (Ad) 45M Users | 32,481% Growth Rate
Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open. Claim Exclusive 100% Bonus: $0.25/Share |
11/22/2023
3:15 PM | BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13D/A | |
11/17/2023
3:27 PM | BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/17/2023
3:27 PM | BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023
3:03 PM | BridgeBio Pharma (Subject)
Valantine Hannah (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
6:31 AM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
3:00 PM | BridgeBio Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
3:00 PM | BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
